AbbVie Inc. (ETR:4AB)
189.80
-1.40 (-0.73%)
Jan 12, 2026, 10:42 AM CET
AbbVie Revenue
AbbVie had revenue of $15.78B USD in the quarter ending September 30, 2025, with 9.10% growth. This brings the company's revenue in the last twelve months to $59.64B, up 7.40% year-over-year. In the year 2024, AbbVie had annual revenue of $56.33B with 3.71% growth.
Revenue (ttm)
$59.64B
Revenue Growth
+7.40%
P/S Ratio
6.58
Revenue / Employee
$1.08M
Employees
55,000
Market Cap
334.39B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 56.33B | 2.02B | 3.71% |
| Dec 31, 2023 | 54.32B | -3.74B | -6.44% |
| Dec 31, 2022 | 58.05B | 1.86B | 3.30% |
| Dec 31, 2021 | 56.20B | 10.39B | 22.69% |
| Dec 31, 2020 | 45.80B | 12.54B | 37.69% |
| Dec 31, 2019 | 33.27B | 513.00M | 1.57% |
| Dec 31, 2018 | 32.75B | 4.54B | 16.08% |
| Dec 31, 2017 | 28.22B | 2.58B | 10.06% |
| Dec 31, 2016 | 25.64B | 2.78B | 12.16% |
| Dec 31, 2015 | 22.86B | 2.90B | 14.52% |
| Dec 31, 2014 | 19.96B | 1.17B | 6.23% |
| Dec 31, 2013 | 18.79B | 410.00M | 2.23% |
| Dec 31, 2012 | 18.38B | 936.00M | 5.37% |
| Dec 31, 2011 | 17.44B | 1.81B | 11.55% |
| Dec 31, 2010 | 15.64B | 1.42B | 10.02% |
| Dec 31, 2009 | 14.21B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.87B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.27B |
| Fresenius Medical Care AG | 19.64B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.42B |
AbbVie News
- 20 hours ago - Notable healthcare headlines for the week: AbbVie, UnitedHealth, and Novo Nordisk in focus - Seeking Alpha
- 1 day ago - MoneyShow's Best Investment Ideas For 2026: Part 1 - Seeking Alpha
- 2 days ago - 2 Healthcare Stocks That Can Diversify a Tech-Heavy Portfolio - The Motley Fool
- 2 days ago - Here's How Much $100 Invested In AbbVie 10 Years Ago Would Be Worth Today - Benzinga
- 2 days ago - See Which Of The Latest 13F Filers Holds ABBV - Nasdaq
- 2 days ago - Here's What We Expect From AbbVie's Immunology Segment in Q4 - Nasdaq
- 3 days ago - AbbVie (ABBV) Shares Cross 3% Yield Mark - Nasdaq
- 3 days ago - AbbVie Stock Drops After Guidance Update, Wolfe Downgrade And Deal Denial - Benzinga